Enforcement Report - Week of June 7, 2023
Enforcement Report - Week of May 24, 2023
Class 2 Medicines Recall: Hikma Pharmaceuticals USA Inc, Lorazepam
Enforcement Report - Week of August 17, 2022
The U.S. Food and Drug Administration announced today in a Drug Safety Communication that it is requiring an update to the Boxed Warning, the agency’s most prominent safety warning, and requiring class-wide labeling changes for benzodiazepines to include the risks of abuse, misuse, addiction, physical dependence and withdrawal reactions to help improve their safe use.
(Reuters Health) - A growing number of people in the U.S. are taking anti-anxiety drugs like Valium and Xanax not just for anxiety or depression but also for chronic pain, researchers say.
Aurobindo Pharma’s Generic Lorazepam Receives Approval In US
Enforcement Report - Week of December 27, 2017
Enforcement Report - Week of November 29, 2017
Amneal Pharmaceuticals Issues Voluntary Nationwide Recall of Lorazepam Oral Concentrate, USP 2mg/mL